Chantico Global's Gina Sanchez: "Microsoft is a long-term hold"
2 Mins read
Chantico Global’s Gina Sanchez: “Microsoft is a long-term hold” Ad disclosure Invezz is an independent platform with the goal of helping users…
Here's why Boston Beer stock is giving investors a hangover
2 Mins read
Here’s why Boston Beer stock is giving investors a hangover | Invezz Ad disclosure Invezz is an independent platform with the goal…
Here's what American Express Q2 results tell us
2 Mins read
American Express beats Wall Street estimates in the fiscal second quarter. Ad disclosure Invezz is an independent platform with the goal of…
Vodafone reiterates full-year outlook as revenue rebounds in Q1
2 Mins read
Vodafone reiterates full-year outlook as revenue rebounds in Q1 Ad disclosure Invezz is an independent platform with the goal of helping users…
Baird reiterates a "Buy" rating for Boeing while two traders call for caution
2 Mins read
Baird reiterates a “Buy” rating for Boeing while two traders call for caution | Invezz Ad disclosure Invezz is an independent platform…
Analyst explains why Intel stock is down despite market-beating results
2 Mins read
Intel Corporation reports market-beating quarterly results. Ad disclosure Invezz is an independent platform with the goal of helping users achieve financial freedom….
Here's why SNAP jumped about 15% in after-hours trading on Thursday
2 Mins read
Snap grows users faster than expected in the fiscal second quarter. Ad disclosure Invezz is an independent platform with the goal of…
Nuveen's Saira Malik: "it could be another quarter of tough comps for Twitter"
2 Mins read
Twitter beats Wall Street estimates in the fiscal second quarter. Ad disclosure Invezz is an independent platform with the goal of helping…
Unilever tumbles despite half-year earnings beat: should you buy the pullback?
2 Mins read
Unilever Plc (LON:ULVR) reported its fiscal half-year results on Thursday before markets opened. The company posted relatively flat revenue growth of 0.03%…
Abbott Labs stock price forecast for Q3 after Q2 results
2 Mins read
The US medical devices company Abbott Laboratories (NYSE:ABT) announced its fiscal Q2 results on Thursday before markets opened. The company posted higher…